Plus Therapeutics Inc
NASDAQ:PSTV

Watchlist Manager
Plus Therapeutics Inc Logo
Plus Therapeutics Inc
NASDAQ:PSTV
Watchlist
Price: 0.2852 USD -1.66%
Market Cap: 39.2m USD

Profitability Summary

Plus Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Plus Therapeutics Inc

Margins Comparison
Plus Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Plus Therapeutics Inc
NASDAQ:PSTV
38.2m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.5B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.6B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Plus Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Plus Therapeutics Inc
NASDAQ:PSTV
38.2m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.6B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Plus Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate